Brian McNamee

Dr McNamee has executive experience in the biopharmaceutical industry, with a focus on strategy. Since leaving his executive role at CSL, Dr McNamee has served as a senior advisor to private equity group Kohlberg Kravis Roberts. He has also pursued several private equity and interests in small cap healthcare companies, and in 2014 served on the panel of the Australian Government's Financial System Inquiry. In 2009, he was made an Officer of the Order of Australia for service to business and commerce. He is a Member of the Innovation and Development Committee, Member of the Disclosure Committee, Member of the Corporate Governance Committee.